In a subgroup analysis of people living with HIV enrolled in PRIOH-1, pritelivir demonstrated superior lesion healing, achieving 61% complete ...
The main market opportunities in HSV-1 keratitis include exploring emerging gene-editing technologies, addressing drug-resistant strains, and targeting the unmet need for more effective therapies. The ...
Krystal is leveraging a validated, redosable platform with high margins, profitability, and multiple blockbuster catalysts in ...
This case report presents a patient who underwent photorefractive keratectomy 13 years after Acanthamoeba infection. The patient experienced prolonged difficulties in epithelialization during the ...
PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform ...
When former Spice Girl Mel B revealed that she was temporarily blinded in one eye due to a herpes-related complication, it shocked many fans and sparked a wave of questions about the virus’s potential ...
Compr Ophthalmol Update. 2005;6(2):85-101. In a 10-week study of three times daily oral acyclovir against placebo, pediatric patients with HSV stromal keratitis who were treated concomitantly with ...
Poster presentation to demonstrate EBT-107’s potential to reduce clinically-relevant biomarkers and HBV DNA integration toward functional remission of chronic hepatitis B Oral presentation to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results